How much does one month of sunitinib treatment cost?

Sunitinib is a multi-target tyrosine kinase inhibitor that is widely used in the treatment of advanced renal cell carcinoma (RCC), gastrointestinal stromal tumors (GIST) and pancreatic neuroendocrine tumors (pNET). Patients are often concerned about the cost of this medication. According to the current market conditions, the cost of one-month treatment with sunitinib varies greatly, which is mainly affected by the source and specifications of the drug and the medical insurance reimbursement policy.

In the Chinese market, the original drug of sunitinib, sunitinib malate capsules, has been launched and has been included in Class B medical insurance. The common specification of this drug is 12.5mg*28 capsules, and the price per box is about 2,000 yuan. According to the standard treatment plan, patients usually need to take 50mg once daily. If the patient follows a regimen of 4 weeks of medication followed by 2 weeks of rest, the overall cost for a month is close to around 10,000 RMB.

In addition, there are some generic drugs from India and other countries on the market, and these drugs are usually more affordable. For example, the price of a 28-tablet package of sunitinib generics produced in India is approximately RMB 800. The approximate cost for a patient to use it for one month is about 4,000 to 5,000 RMB. This undoubtedly provides more choices for some patients with heavy financial burdens, but they still need to be cautious when choosing to ensure the quality and reliability of the drugs.

In addition to the cost of the drug itself, patients also need to consider other related medical expenses during treatment, such as regular examinations, monitoring of side effects, and possible supportive care. These fees also have an impact on the overall cost of treatment. Therefore, patients should consider all expenses when calculating the total cost of sunitinib treatment.

Medical insurance coverage provides patients with certain financial support and helps reduce their financial burden during anti-tumor treatment. Patients can communicate with doctors to understand the cost compensation policy that suits them, thereby optimizing treatment plans and reducing out-of-pocket expenses.

Reference materials:https://www.sutent.com/